Exact Sciences’ Precision Oncology Portfolio of Tests
Treatment Determination
The Oncotype DX® tests deliver clinically relevant genomic intelligence specific to the individual biology of a patient’s tumor—equipping physicians with the Exact insights they need.
Therapy Selection
Inform treatment options for those facing the challenges of advanced-stage cancer.
Raise your Exactations
with genomic information for each patient’s situation.
News & Events
FOR PATIENTS
Genomic testing can help inform the right cancer treatment decision for you
It's important to know everything you can about genomic tests; that way, you and your doctor can make an informed decision together.
Real patients share their stories of inspiration
-
Meet DeepaA surgeon diagnosed with node negative, invasive breast cancer who used the Oncotype DX Breast Recurrence Score test to help inform a decision to not get chemotherapy.
Deepa's Story
A surgeon diagnosed with node negative, invasive breast cancer who used the Oncotype DX Breast Recurrence Score test to help inform a decision to not get chemotherapy... -
Amy's Oncotype DX Breast DCIS Score StoryAmy, a breast cancer survivor, describes her experience using Genomic Health's Oncotype DX DCIS Breast Cancer Score to personalize her treatment options. Share this video with your loved ones to help empower other women facing a DCIS (ductal carcinoma in situ) breast cancer diagnosis to ask for personalized treatment. For more information, please visit: www.genomichealth.com www.oncotypedx.com
Amy’s Story
A radiology technician diagnosed with ductal carcinoma in situ (DCIS) who used the Oncotype DX Breast DCIS Score test to help her learn that her likelihood of tumor recurrence was very low... -
Lloyd and His Wife Discuss Prostate Cancer Treatments and Active SurveillanceWhen it comes to prostate cancer, communication is vital, not only with a patient's doctor, but with their partner as well. We join Lloyd and his wife as they, with the help of Dr. Ketan Badani, learn that surgery and radiation are not the only treatment options.
Lloyd’s Story
A financial executive diagnosed with early-stage prostate cancer who used his Oncotype DX Genomic Prostate Score result to choose active surveillance over invasive treatment...
Billing & Coverage
Exact Sciences believes that everyone should have access to the information they need to make informed decisions about their cancer treatment. That’s why we offer the Genomic Access Program (GAP) to help patients navigate the insurance and billing process.
We’ve set the Exactations high
Over 1 million patients benefited from Oncotype DX® tests
Helping them avoid over/undertreatment in breast, prostate, and colon cancers.